Terra Innovatum Global N.V. (NKLR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
16 Oct, 2026Executive summary
AGM scheduled for 16 November 2026; agenda includes FY2025 accounts, director appointments, remuneration changes, share repurchase authority and KPMG audit withdrawal.
Board says FY2025 accounts preparation was delayed by special circumstances; preparation is now complete, and shareholders are asked to approve a five-month statutory extension.
Voting matters and shareholder proposals
Shareholders will vote on FY2025 accounts adoption and director discharge for duties disclosed in the accounts or otherwise publicly disclosed before adoption.
Proposed Board authorization to acquire up to 10% of issued capital for 18 months after the AGM, at no more than 110% of the preceding five-trading-day average closing price; no current intent to use it.
Resolutions generally pass by a simple majority of votes cast; abstentions, blank, invalid and broker non-votes are excluded.
Board of directors and corporate governance
Proposed director terms run through the close of the 2027 AGM; nominees include executive directors Alessandro Petruzzi and Massimo Morichi, and executive director/CFO Katherine Crocker Williams.
Five proposed non-executive appointees are Joanna Lyn Lohkamp, Kostadin Ivanov, Mamdouh El-Shanawany, S. Michael Modro and Tony Tullio, bringing experience across boards, nuclear engineering, safety and finance.
Nominees were proposed by binding Board nomination; under the articles, directors are appointed for a maximum one-year term and may be reappointed.
Latest events from Terra Innovatum Global N.V.
- Proposed governance and pay changes accompany an auditor transition and unremediated control weaknesses.NKLR
Proxy filing - Q2 2026 net loss was $18M on $6.1M expenses; $91.1M cash, no revenue, commercialization in 2028.NKLR
Q2 2026 - Micromodular reactor SOLO secures $4B in commitments, targeting rapid, global deployment.NKLR
Canaccord Genuity's 46th Annual Growth Conference - Q1 2026 net loss rose to $7.1M as R&D spending increased and no revenue was generated.NKLR
Q1 2026 - Factory-built microreactors with secured supply chain and $4B in commitments target 2027 launch.NKLR
Investor presentation - $4B in commitments, $102.9M cash, no debt, FOAK in 2027, commercialization in 2028.NKLR
Q4 2025 - $4B in commitments, regulatory progress, and full funding drive 2027 FOAK deployment.NKLR
Investor update - Safe, scalable microreactors with secured funding and supply chain target 2027 deployment.NKLR
Investor presentation - Factory-built micro-reactors offer safe, scalable, low-cost energy for diverse markets.NKLR
Investor presentation